PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711
Recalling firm: Beta Labs
Why it was recalled
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
The exact product
PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802
Check the codes
Compare these FDA-provided codes, lot numbers or dates with the product you have.
Match the product, size and code together. A similar name alone does not identify your batch.
Original FDA code information
Lot # 1205129, Exp 12/16
| Type | Code / value | Context |
|---|---|---|
| UPC | 029882559802 | L GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802 |
| lot | 1205129 | Lot # 1205129, Exp 12/16 |
Recall details
- Recall number
- F-2400-2014
- Event ID
- 65585
- FDA status
- Terminated
- Initiated
- Jun 20, 2013
- Reported
- Sep 3, 2014
- Classified
- Aug 27, 2014
- Terminated
- Dec 3, 2014
- Quantity
- 743 units
- Location
- Memphis, TN, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Press Release
Where it was distributed
nationwide and UK
FDA source record · F-2400-2014
Data updated September 16, 2026. View official FDA data ↗
A missing code match is not a guarantee of safety. Follow official FDA and manufacturer guidance.